✦ LIBER ✦

Regulatory Considerations for Manufacturing and Delivery of Cell-based Therapies for Cardiovascular Indications

✍ Scribed by Darin J. Weber

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cell Therapy for Cardiovascular Disease:

✍ Nabil Dib; Harris Khawaja; Samantha Varner; Megan McCarthy; Ann Campbell 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 119 KB

Progress and prospects: Cell based regen

✍ de Muinck, E D; Thompson, C; Simons, M 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 251 KB

Renal and cardiovascular considerations

✍ Zhang, R; Thakur, V; Morse, S; Reisin, E 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 125 KB

Review of Stem Cell-Based Therapy for th

✍ Cindy M. Martin 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 184 KB

Cell-Based Therapies for Disorders of th

✍ Steven A. Goldman; Fraser J. Sim 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 55 KB

Present Status and Perspectives of Stem

✍ Li Yan; Changhao Cai; Jun Li; Shiping Xu; Qing Chang; Yingnan Li; Benyan Wu 📂 Article 📅 2009 🏛 Humana Press Inc 🌐 English ⚖ 184 KB